Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Normal Hemopoiesis

Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factor

Leukemia volume 20, pages 1430–1434 (2006)Cite this article

Abstract

Recombinant human G-CSF (rHuG-CSF) is used for hematopoietic progenitor cells (HPC) mobilization and collection. Activation of polymorphonuclear leukocytes (PMN) is present during rHuG-CSF treatment and is associated with endothelial cell dysfunction and hypercoagulation. We evaluated whether PMN activation by rHuG-CSF may alter the blood oxidative status and subsequently affect the vascular cell function. Fourteen healthy individuals received rHuG-CSF for HPC harvesting. Blood was drawn before starting rHuG-CSF (T0), on the last day of rHuG-CSF (T1) and 1 week after stopping rHuG-CSF (T2). Levels of CD11b, myeloperoxidase (MPO), hydroperoxides, nitric oxide (NO), and soluble endothelium (sES), leukocyte (sLS), and platelet (sPS) selectins were measured. During rHuG-CSF, CD11b, MPO and hydroperoxides significantly increased, while NO levels significantly decreased, compared with T0. At T2 all these markers returned to baseline values. Significant increments of all selectins were observed during rHuG-CSF. At T2 sES and sEP significantly decreased back to pre-treatment values, whereas sLS remained significantly high. These data show that rHuG-CSF induces a transient inflammatory status characterized by circulating activated PMN, which release reactive oxygen species and intracellular proteases, promoting the onset of an abnormal oxidative status. This process may modify the hemostatic balance towards a pro-thrombotic state.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Lieschke GJ, Burgess AW . Granulocyte colony-stimulating factor and granulocyte-macrophage colony stimulating factor. New Engl J Med 1992; 327: 99–106.

    Article  CAS  Google Scholar 

  2. Gabrilove J . The development of granulocyte colony-stimulating factor in its various clinical applications. Blood 1992; 80: 1382–1385.

    CAS  PubMed  Google Scholar 

  3. Barbui T, Finazzi G, Grassi A, Marchioli R . Thrombosis in cancer patients treated with hematopoietic growth factors – a meta-analysis. On behalf of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1996; 75: 368–371.

    CAS  PubMed  Google Scholar 

  4. Falanga A, Marchetti M, Evangelista V, Evangelista V, Manarini S, Oldani E et al. Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor. Blood 1999; 93: 2506–2514.

    CAS  PubMed  Google Scholar 

  5. Nathan CF . Respiratory burst in adherent human neutrophils: triggering by colony-stimulating factors CSF-GM. Blood 1979; 73: 301–306.

    Google Scholar 

  6. Sullivan R, Griffin JD, Simons ER, Schafer AI, Meshulam T, Fredette JP et al. Effects of recombinant human granulocyte and macrophage-stimulating factors on signal transduction pathways in human granulocytes. J Immunol 1987; 139: 3422–3430.

    CAS  PubMed  Google Scholar 

  7. Ohsaka A, Kitagawa S, Sakamoto S, Miura Y, Takanashi N, Takaku F et al. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma. Blood 1989; 74: 2743–2748.

    CAS  PubMed  Google Scholar 

  8. Varani J, Ginsburg I, Schuger L, Gibbs DF, Bromberg J, Johnson KJ et al. Endothelial cell killing by neutrophils. Synergistic interaction of oxygen products and proteases. Am J Pathol 1989; 135: 435–438.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Weksler BB, Jaffe EA, Brower MS, Cole OF . Human leukocyte cathepsin G and elastase specifically suppress Thrombin-induced prostacyclin production in human endothelial cells. Blood 1989; 74: 1627–1634.

    CAS  PubMed  Google Scholar 

  10. Cesarone MR, Belcaro G, Carratelli M, Cornelli U, De Sanctis MT, Incandela L et al. A simple test to monitor oxidative stress. Int Angiol 1999; 18: 127–130.

    CAS  PubMed  Google Scholar 

  11. Ohsaka A, Saijnoi K, Igari J . Granulocyte colony stimulating factor administration increases serum concentrations of soluble selectins. Br J Haematol 1998; 100: 66–69.

    Article  CAS  Google Scholar 

  12. Walford G, Loscalzo J . Nitric oxide in vascular biology. J Thromb Haemost 2003; 1: 2112–2118.

    Article  CAS  Google Scholar 

  13. Falanga A, Marchetti M, Evangelista V, Vignoli A, Licini M, Balicco M et al. Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. Blood 2000; 96: 4261–4266.

    CAS  PubMed  Google Scholar 

  14. Eiserich JP, Baldus S, Brennan M-L, Ma W, Zhang C, Tousson A et al. Myeloperoxidase, a leucocyte-derived vascular NO oxidase. Science 2002; 296: 2391–2394.

    Article  CAS  Google Scholar 

  15. Wykretowicz A, Dziarmaga M, Szczepanik A, Guzik P, Wysocki H . Prospective evaluation of hydroperoxide plasma levels and stabile nitric oxide end products in patients subjected to angioplasty for coronary artery disease. Int J Cardiol 2003; 89: 173–178.

    Article  CAS  Google Scholar 

  16. McEver RP . GMP-140, an inducible granule membrane protein of platelets and endothelium. Blood Cells 1990; 16: 73–80.

    CAS  PubMed  Google Scholar 

  17. Fijnheer R, Frijns CJM, Korteweg J, Rommes H, Peters JH, Sixma JJ et al. The origin of P-selectin as circulating plasma protein. Thromb Haemost 1997; 77: 1081–1085.

    Article  CAS  Google Scholar 

  18. Renosto P, Chignard M . Enhancement of cathepsin C-induced platelet activation by leukocyte elastase: consequence for the-mediated platelet activation. Blood 1993; 82: 139–144.

    Google Scholar 

  19. Spertini O, Schleiffenbaum B, White-Owen C, Tedder TF . ELISA for quantification of L-selectin shed from leukocytes in vivo. J Immunol Methods 1992; 156: 115–123.

    Article  CAS  Google Scholar 

  20. Vij R, Adkins DR, Brown RA, Khoury H, DiPersio JF, Goodnough T . Unstable angina in a peripheral blood stem and progenitor cell donor given granulocyte-colony stimulating factor. Transfusion 1999; 39: 542–543.

    Article  CAS  Google Scholar 

  21. Leitman SF, Oblitas JM, Bolan CD . Crescendo angina during granulocytapheresis in a G-CSF stimulated donor. Transfusion 2001; 41: 36S.

    Google Scholar 

  22. Hill JM, Syed MA, Arai AE, Powell TM, Paul JD, Zalos G et al. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J Am Coll Cardiol 2005; 46: 1643–1648.

    Article  CAS  Google Scholar 

  23. Fukumoto Y, Miyamoto T, Okamura T, Gondo H, Iwasaki H, Horiuchi T et al. Angina pectoris occurring during granulocyte colony-stimulating factor-combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia. Br J Haematol 1997; 9: 666–668.

    Article  Google Scholar 

  24. Falanga A, Marchetti M, Vignoli A, Balducci D, Barbui T . Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera. Exp Hematol 2005; 33: 523–530.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Reasearch support: This work was supported in part by grant 60% of MURST

Author information

Authors and Affiliations

  1. Department of Scienze Mediche e Chirurgiche, Università degli Studi di Padova, Padova, Italy

    G Cella, M L Randi, G Saggiorato, L Pasetto & A Pagnan

  2. Department of Hematology-Oncology, Ospedali Riuniti di Bergamo, Bergamo, Italy

    M Marchetti, A Vignoli, T Barbui & A Falanga

Authors
  1. G Cella
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Marchetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Vignoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M L Randi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G Saggiorato
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L Pasetto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A Pagnan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T Barbui
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A Falanga
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Falanga.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cella, G., Marchetti, M., Vignoli, A. et al. Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factor. Leukemia 20, 1430–1434 (2006). https://doi.org/10.1038/sj.leu.2404271

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404271

Keywords

This article is cited by

Search

Advanced search

Quick links